作者：
Verstovsek, Srdan [1]
;
Vannucchi, Alessandro M. [2]
;
Griesshammer, Martin [3]
;
Masszi, Tamas [4]
;
Durrant, Simon [5]
;
Passamonti, Francesco [6]
;
Harrison, Claire N. [7]
;
Pane, Fabrizio [8]
;
Zachee, Pierre [9]
;
Kirito, Keita [10]
;
Besses, Carlos [11]
;
Hino, Masayuki [12]
;
Moiraghi, Beatriz [13]
;
Miller, Carole B. [14]
;
Cazzola, Mario [15]
;
Rosti, Vittorio [16]
;
Blau, Igor [17]
;
Mesa, Ruben [18]
;
Jones, Mark M. [19]
;
Zhen, Huiling [20]
;
Li, Jingjin [21]
;
Francillard, Nathalie [22]
;
Habr, Dany ;
Kiladjian, Jean-Jacques
作者单位：
St Agnes Canc Inst, Baltimore, MD USA
[1]
IRCCS Policlin San Matteo Fdn, Ctr Study Myelofibrosis, Pavia, Italy
[2]
Royal Brisbane & Womens Hosp, Brisbane, Qld, Australia
[3]
ZNA Stuivenberg, Antwerp, Belgium
[4]
Hosp Mar, Hematol Dept, Barcelona, Spain
[5]
Novartis Pharma SAS, Rueil Malmaison, France
[6]
Novartis Pharmaceut, E Hanover, NJ USA
[7]
Hop St Louis, INSERM CIC 1427, Ctr Invest Clin, Paris, France
[8]
Univ Florence, AOU Careggi, Ctr Res & Innovat Myeloproliferat Neoplasms, I-50121 Florence, Italy
[9]
Univ Insubria, Dept Clin & Expt Med, Varese, Italy
[10]
Osaka City Univ, Grad Sch Med, Dept Clin Hematol & Diagnost, Osaka, Japan
[11]
Univ Pavia, Dept Hematol, I-27100 Pavia, Italy
[12]
Univ Yamanshi, Dept Hematol & Oncol, Chuo, Japan
[13]
Incyte Corp, Wilmington, DE USA
[14]
Guys & St Thomas NHS Fdn Trust, London, England
[15]
Johannes Wesling Clin, Minden, Germany
[16]
Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[17]
Semmelweis Univ, Dept Internal Med 3rd, St Istvan & St Laszlo Hosp, Budapest, Hungary
[18]
Charite Univ Med Berlin, Div Hematol Oncol & Tumor Immunol, Med Dept, Berlin, Germany
[19]
Univ Naples Federico II, Naples, Italy
[20]
Mayo Clin, Ctr Canc, Dept Hematol Oncol, Scottsdale, AZ USA
[21]
Hosp Jose Maria Ramos Mejia, Buenos Aires, DF, Argentina
[22]
发布时间
2017-04-06
换一批
换一批
